BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18035424)

  • 1. Detection of full-length and truncated neurokinin-1 receptor mRNA expression in human brain regions.
    Lai JP; Cnaan A; Zhao H; Douglas SD
    J Neurosci Methods; 2008 Feb; 168(1):127-33. PubMed ID: 18035424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurokinin-1 receptor mRNA expression differences in brains of HIV-infected individuals.
    Douglas SD; Lynch KG; Lai JP
    J Neurol Sci; 2008 Sep; 272(1-2):174-7. PubMed ID: 18572194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptor.
    Lai JP; Lai S; Tuluc F; Tansky MF; Kilpatrick LE; Leeman SE; Douglas SD
    Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12605-10. PubMed ID: 18713853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurokinin-1 receptor expression and function in human macrophages and brain: perspective on the role in HIV neuropathogenesis.
    Douglas SD; Lai JP; Tuluc F; Schwartz L; Kilpatrick LE
    Ann N Y Acad Sci; 2008 Nov; 1144():90-6. PubMed ID: 19076368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of neurokinin-1 receptor messenger RNA expression in synovial fibroblasts of patients with rheumatoid arthritis.
    Akasaka Y; Abe K; Sato T; Inoue H
    Neuropeptides; 2005 Oct; 39(5):467-74. PubMed ID: 16154193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of the full-length transcript variant for neurokinin-1 receptor in human whole blood associated with enhanced reinforcement of clot by substance-P.
    Azma T; Sugimoto Y; Kinoshita H; Ito T; Tsukamoto M; Hoshijima H; Nakao M; Kikuchi H
    J Thromb Thrombolysis; 2012 May; 33(4):329-37. PubMed ID: 22057425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer.
    Zhou Y; Zhao L; Xiong T; Chen X; Zhang Y; Yu M; Yang J; Yao Z
    Breast Cancer Res Treat; 2013 Jul; 140(1):49-61. PubMed ID: 23807418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance P Receptor Antagonist Suppresses Inflammatory Cytokine Expression in Human Disc Cells.
    Kepler CK; Markova DZ; Koerner JD; Mendelis J; Chen CM; Vaccaro AR; Risbud MV; Albert TJ; Anderson DG
    Spine (Phila Pa 1976); 2015 Aug; 40(16):1261-9. PubMed ID: 25929203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of the tachykinins substance P/neurokinin A/hemokinin-1 and their preferred neurokinin 1/neurokinin 2 receptors in uterine leiomyomata.
    González-Santana A; Marrero-Hernández S; Dorta I; Hernández M; Pinto FM; Báez D; Bello AR; Candenas L; Almeida TA
    Fertil Steril; 2016 Nov; 106(6):1521-1529. PubMed ID: 27456549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning of a C-terminally truncated NK-1 receptor from guinea-pig nervous system.
    Baker SJ; Morris JL; Gibbins IL
    Brain Res Mol Brain Res; 2003 Mar; 111(1-2):136-47. PubMed ID: 12654513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R).
    Chernova I; Lai JP; Li H; Schwartz L; Tuluc F; Korchak HM; Douglas SD; Kilpatrick LE
    J Leukoc Biol; 2009 Jan; 85(1):154-64. PubMed ID: 18835883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
    Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
    J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a transgenic model to address regulation and function of the human neurokinin 1 receptor (NK1R).
    Vasiliou AS; MacKenzie A; Morris R; McLaughlin L; Bubb VJ; Haddley K; Quinn JP
    Neuropeptides; 2007 Aug; 41(4):195-205. PubMed ID: 17576012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of CP96,345 on the expression of tachykinins and neurokinin receptors in acute pancreatitis.
    Lau HY; Bhatia M
    J Pathol; 2006 Feb; 208(3):364-71. PubMed ID: 16369913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased level of neurokinin-1 tachykinin receptor gene expression during early postnatal development of rat brain.
    Taoka M; Song SY; Kubota M; Minegishi A; Yamakuni T; Konishi S
    Neuroscience; 1996 Oct; 74(3):845-53. PubMed ID: 8884780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of the neurokinin-1 receptor in equine intestinal smooth muscle.
    Solinger N; Sonea IM
    Equine Vet J; 2008 Jun; 40(4):321-5. PubMed ID: 18267878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis.
    Zhang L; Wang L; Dong D; Wang Z; Ji W; Yu M; Zhang F; Niu R; Zhou Y
    Cell Prolif; 2019 Jan; 52(1):e12527. PubMed ID: 30334298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution and polysome association of full-length and 3' truncated preproenkephalin mRNA in the guinea-pig brain.
    LaForge KS; Ho A; Kreek MJ
    Brain Res Mol Brain Res; 1997 Jun; 46(1-2):169-76. PubMed ID: 9191091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of substance P, neurokinin-1 receptor and immune markers in the brains of individuals with HIV-associated neuropathology.
    Spitsin S; Stevens KE; Douglas SD
    J Neurol Sci; 2013 Nov; 334(1-2):18-23. PubMed ID: 23916293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a NK1R-CreER knockin mouse strain to study cells involved in Neurokinin 1 Receptor signaling.
    Huang H; Kuzirian MS; Cai X; Snyder LM; Cohen J; Kaplan DH; Ross SE
    Genesis; 2016 Nov; 54(11):593-601. PubMed ID: 27712014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.